Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Kiwa Bio-Tech Products Group Corp KWBT

Kiwa Bio-Tech Products Group Corporation develops, manufactures, distributes and markets bio-technological products for agriculture. The Company operates primarily in the mainland China. The Company's products include biological organic fertilizer series, compound microbial fertilizer series, biological water-soluble fertilizer series, microorganism bacterium agent series and biological soil... see more

Bullboard (GREY:KWBT)

View:
Post by Stocks101007on Jan 20, 2020 9:58am

PRICE TARGET $2.70

PT $2.70 ,!! https://www.goldmanresearch.com/201902141231/Opportunity-Research/kiwa-bio-tech-pure-play-on-agbiotech-in-china.html
Post by Stocks101007on Jan 20, 2020 9:55am

PRICE TARGET $2.70

PT $2.70 ,!! https://www.goldmanresearch.com/201902141231/Opportunity-Research/kiwa-bio-tech-pure-play-on-agbiotech-in-china.html
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities